Skip to main content
The BMJ logoLink to The BMJ
. 1989 Mar 25;298(6676):809–812. doi: 10.1136/bmj.298.6676.809

One hundred pregnancies after treatment with pulsatile luteinising hormone releasing hormone to induce ovulation.

R Homburg 1, A Eshel 1, N A Armar 1, M Tucker 1, P W Mason 1, J Adams 1, J Kilborn 1, I A Sutherland 1, H S Jacobs 1
PMCID: PMC1836076  PMID: 2496866

Abstract

OBJECTIVE--To review treatment with pulsatile luteinising hormone releasing hormone in infertile women who do not ovulate and are resistant to clomiphene after 100 pregnancies achieved with this treatment. DESIGN--Retrospective analysis of 146 courses of treatment over 434 cycles. SETTING--Infertility clinic. PATIENTS--118 Women whose failure to ovulate was due to idiopathic hypogonadotrophic hypogonadism (n = 39), amenorrhoea related to low weight (n = 17), organic pituitary disease (n = 15), or polycystic ovaries (n = 47). INTERVENTIONS--Dose of 15 micrograms luteinising hormone releasing hormone/pulse subcutaneously every 90 minutes given with a miniaturised pump throughout cycle monitored by ultrasound. Women with hypogonadotrophic hypogonadism had 48 courses, women with amenorrhoea related to low weight 23, women with organic pituitary disease 18, and women with polycystic ovaries 57. END POINT--Follow up of 100 pregnancies achieved in 77 women during six years after introducing treatment. MEASUREMENTS and main results--One hundred pregnancies (seven multiple, 28 miscarriages). Cumulative rates of pregnancy were 93-100% at six months in women with idiopathic hypogonadotrophic hypogonadism, amenorrhoea related to low weight, and organic pituitary disease. In women with polycystic ovaries (cumulative rate of pregnancy 74%) adverse prognostic factors were obesity, hyperandrogenism, and high luteinising hormone concentrations, which were also associated with a high rate of early pregnancy loss. CONCLUSIONS--Treatment with pulsatile luteinising hormone releasing hormone is safe, simple, and effective, and the preferred method of inducing ovulation in appropriately selected patients. Compared with exogenous gonadotrophin treatment there is little need for monitoring, no danger of hyperstimulation, and a low rate of multiple pregnancies.

Full text

PDF
809

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armar N. A., Tan S. L., Eshel A., Jacobs H. S., Adams J., Sutherland I. A. Practical aspects of pulsatile LHRH therapy. Br J Hosp Med. 1987 May;37(5):429-31, 434-6. [PubMed] [Google Scholar]
  2. Crowley W. F., Jr, Filicori M., Spratt D. I., Santoro N. F. The physiology of gonadotropin-releasing hormone (GnRH) secretion in men and women. Recent Prog Horm Res. 1985;41:473–531. doi: 10.1016/b978-0-12-571141-8.50015-9. [DOI] [PubMed] [Google Scholar]
  3. Eshel A., Abdulwahid N. A., Armar N. A., Adams J. M., Jacobs H. S. Pulsatile luteinizing hormone-releasing hormone therapy in women with polycystic ovary syndrome. Fertil Steril. 1988 Jun;49(6):956–960. doi: 10.1016/s0015-0282(16)59943-9. [DOI] [PubMed] [Google Scholar]
  4. Homburg R., Armar N. A., Eshel A., Adams J., Jacobs H. S. Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. BMJ. 1988 Oct 22;297(6655):1024–1026. doi: 10.1136/bmj.297.6655.1024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Homburg R., Eshel A., Armar N. A., Tucker M., Adams J., Jacobs H. S. Synergism of pulsatile LHRH therapy with oral clomiphene treatment. Gynecol Endocrinol. 1988 Mar;2(1):59–66. doi: 10.3109/09513598809029340. [DOI] [PubMed] [Google Scholar]
  6. Hull M. G., Savage P. E., Jacobs H. S. Investigation and treatment of amenorrhoea resulting in normal fertility. Br Med J. 1979 May 12;1(6173):1257–1261. doi: 10.1136/bmj.1.6173.1257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Jacobs H. S., Hull M. G., Murray M. A., Franks S. Therapy-orientated diagnosis of secondary amenorrhoea. Horm Res. 1975;6(4):268–287. doi: 10.1159/000178700. [DOI] [PubMed] [Google Scholar]
  8. Leyendecker G., Wildt L., Hansmann M. Pregnancies following chronic intermittent (pulsatile) administration of Gn-RH by means of a portable pump ("Zyklomat")--a new approach to the treatment of infertility in hypothalamic amenorrhea. J Clin Endocrinol Metab. 1980 Nov;51(5):1214–1216. doi: 10.1210/jcem-51-5-1214. [DOI] [PubMed] [Google Scholar]
  9. Mason P., Adams J., Morris D. V., Tucker M., Price J., Voulgaris Z., Van der Spuy Z. M., Sutherland I., Chambers G. R., White S. Induction of ovulation with pulsatile luteinising hormone releasing hormone. Br Med J (Clin Res Ed) 1984 Jan 21;288(6412):181–185. doi: 10.1136/bmj.288.6412.181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Morris D. V., Abdulwahid N. A., Armar A., Jacobs H. S. The response of patients with organic hypothalamic-pituitary disease to pulsatile gonadotropin-releasing hormone therapy. Fertil Steril. 1987 Jan;47(1):54–59. doi: 10.1016/s0015-0282(16)49935-8. [DOI] [PubMed] [Google Scholar]
  11. Polson D. W., Sagle M., Mason H. D., Kiddy D., Franks S. Recovery of luteal function after interruption of gonadotrophin secretion in the mid-luteal phase of the menstrual cycle. Clin Endocrinol (Oxf) 1987 May;26(5):597–600. doi: 10.1111/j.1365-2265.1987.tb00815.x. [DOI] [PubMed] [Google Scholar]
  12. Sutherland I. A., White S., Chambers G. R., Rothwell D., Mason P. W., Tucker M., Jacobs H. S. A miniature infuser for the pulsatile administration of LHRH. J Biomed Eng. 1984 Apr;6(2):129–133. doi: 10.1016/0141-5425(84)90055-4. [DOI] [PubMed] [Google Scholar]
  13. Yen S. S., Tsai C. C., Naftolin F., Vandenberg G., Ajabor L. Pulsatile patterns of gonadotropin release in subjects with and without ovarian function. J Clin Endocrinol Metab. 1972 Apr;34(4):671–675. doi: 10.1210/jcem-34-4-671. [DOI] [PubMed] [Google Scholar]
  14. van der Spuy Z. M., Steer P. J., McCusker M., Steele S. J., Jacobs H. S. Outcome of pregnancy in underweight women after spontaneous and induced ovulation. Br Med J (Clin Res Ed) 1988 Apr 2;296(6627):962–965. doi: 10.1136/bmj.296.6627.962. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES